Georgia

216
-1

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
216
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Georgia

  1. 1. Overview of HIV/AIDS in Georgia Ketevan Mshvidobadze, MD, PhD
  2. 2. Women 524 Men 1526 Distribution of HIV/AIDS Patients by Sex and Age Groups Age distribution 2050 Infectious Diseases, AIDS & Clinical Immunology Research Center AIDS - 1044 Deaths - 440
  3. 4. HIV Cases Registered in Georgia Annually Number of cases Infectious Diseases, AIDS & Clinical Immunology Research Center
  4. 5. Distribution of HIV Cases by Routes of Transmission Infectious Diseases, AIDS & Clinical Immunology Research Center
  5. 6. Universal Access to HIV Treatment, Care and Support and Prevention Georgia Is the First Among FSU Countries that from 2004 Ensured Universal (100%) Access to ARV Treatment. Infectious Diseases, AIDS & Clinical Immunology Research Center
  6. 7. RUS * ARM* KAZ* KGZ* UZB* TKM TJK* AZE* BEL* UKR * no HAART individuals on HAART (<1%) * in the process of scaling up ART very poor access ( 1-25%) poor access (25-50%) disputed coverage estimates or insufficient data available moderate access (50-75%) good access (over 75%) ALB* FYM* GEO Access to HAART, 2008
  7. 8. National AIDS Center Three Regional AIDS Treatment Centers Tbilisi Batumi Zugdidi Kutaisi Infectious Diseases, AIDS & Clinical Immunology Research Center Decentralisation of HIV Treatment and Care Process in Georgia
  8. 9. ARV Treatment 547 Patients are currently receiving ART 521 adults 26 children Infectious Diseases, AIDS & Clinical Immunology Research Center
  9. 10. Salvage Regimens – WHO (Regimens for highly treatment experienced patients) <ul><li>Currently available: </li></ul><ul><ul><li>Enfurvitide (Fusion inhibitor) </li></ul></ul><ul><ul><li>Darunavir (PI) </li></ul></ul><ul><li>Starting 2010 through extended Global Fund project: </li></ul><ul><ul><li>Raltegravir (Integrase inhibitor) </li></ul></ul><ul><ul><li>Etravirine (NNRTI) </li></ul></ul><ul><ul><li>Tipranavir (PI) </li></ul></ul><ul><ul><li>Maraviroc (Entry inhibitor) </li></ul></ul>Infectious Diseases, AIDS & Clinical Immunology Research Center
  10. 11. Thank you

×